Back
Direxion Daily S&P Biotech Bull 3X ETF Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
LABU
Direxion Daily S&P Biotech Bull 3X ETF
Last Price:
113.58
Seasonality Move:
18.53%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Direxion Daily S&P Biotech Bull 3X ETF Price Quote
$113.58
+6.81 (+6.38%)
(Updated: November 22, 2024 at 5:55 PM ET)
Direxion Daily S&P Biotech Bull 3X ETF Key Stats
Sell
22
Direxion Daily S&P Biotech Bull 3X ETF (LABU)
is a Sell
Day range:
$101.69 - $110.73
52-week range:
$66.80 - $176.99
Dividend yield:
0.53%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
2M
Avg. volume:
1.1M
1-year change:
58.41%
Market cap:
$0
Revenue:
$0
EPS:
$0
How Much Does Direxion Daily S&P Biotech Bull 3X ETF Make?
Data Unavailable
Is Direxion Daily S&P Biotech Bull 3X ETF Growing As A Company?
Data Unavailable
Direxion Daily S&P Biotech Bull 3X ETF Stock Price Performance
-
Did Direxion Daily S&P Biotech Bull 3X ETF Stock Go Up Last Month?
Direxion Daily S&P Biotech Bull 3X ETF share price went down by -14.29% last month -
Did LABU's Share Price Rise Over The Last Year?
LABU share price rose by 58.41% over the past 1 year
What Is Direxion Daily S&P Biotech Bull 3X ETF 52-Week High & Low?
-
What Is Direxion Daily S&P Biotech Bull 3X ETF’s 52-Week High Share Price?
Direxion Daily S&P Biotech Bull 3X ETF has traded as high as $176.99 over the past 52 weeks -
What Is Direxion Daily S&P Biotech Bull 3X ETF’s 52-Week Low Share Price?
Direxion Daily S&P Biotech Bull 3X ETF has traded as low as $66.80 over the past 52 weeks
Direxion Daily S&P Biotech Bull 3X ETF Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Direxion Daily S&P Biotech Bull 3X ETF?
Data Unavailable
Is Direxion Daily S&P Biotech Bull 3X ETF Cash Flow Positive?
Data Unavailable
Direxion Daily S&P Biotech Bull 3X ETF Return On Invested Capital
Data Unavailable
Direxion Daily S&P Biotech Bull 3X ETF Earnings Date & Stock Price
-
What Is Direxion Daily S&P Biotech Bull 3X ETF's Stock Price Today?
A single share of LABU can be purchased today for 106.77 -
What Is Direxion Daily S&P Biotech Bull 3X ETF’s Stock Symbol?
Direxion Daily S&P Biotech Bull 3X ETF trades on the nysearca under the ticker symbol: LABU -
When Is Direxion Daily S&P Biotech Bull 3X ETF’s Next Earnings Date?
The next quarterly earnings date for Direxion Daily S&P Biotech Bull 3X ETF is scheduled on November 23, 2024 -
When Is LABU's next ex-dividend date?
Direxion Daily S&P Biotech Bull 3X ETF's next ex-dividend date is June 25, 2024 -
How To Buy Direxion Daily S&P Biotech Bull 3X ETF Stock?
You can buy Direxion Daily S&P Biotech Bull 3X ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Direxion Daily S&P Biotech Bull 3X ETF Competitors
-
Who Are Direxion Daily S&P Biotech Bull 3X ETF's Competitors?
Below is a list of companies who compete with Direxion Daily S&P Biotech Bull 3X ETF or are related in some way:
Direxion Daily S&P Biotech Bull 3X ETF Dividend Yield
-
What Is LABU Dividend Yield?
Direxion Daily S&P Biotech Bull 3X ETF’s dividend yield currently is 0.53% -
What Is Direxion Daily S&P Biotech Bull 3X ETF’s Payout Ratio?
Direxion Daily S&P Biotech Bull 3X ETF’s payout ratio is 0% -
When Did Direxion Daily S&P Biotech Bull 3X ETF Last Pay A Dividend?
The latest dividend pay date is November 23, 2024 -
What Is Direxion Daily S&P Biotech Bull 3X ETF’s Dividend Per Share?
Direxion Daily S&P Biotech Bull 3X ETF pays a dividend of $0.00 per share
Direxion Daily S&P Biotech Bull 3X ETF Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable